ES352822A1 - Procedimiento para la produccion de derivados de fenotiaci-na. - Google Patents

Procedimiento para la produccion de derivados de fenotiaci-na.

Info

Publication number
ES352822A1
ES352822A1 ES352822A ES352822A ES352822A1 ES 352822 A1 ES352822 A1 ES 352822A1 ES 352822 A ES352822 A ES 352822A ES 352822 A ES352822 A ES 352822A ES 352822 A1 ES352822 A1 ES 352822A1
Authority
ES
Spain
Prior art keywords
tetrahydrofuryl
piperidine
oxo
hydroxy
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES352822A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of ES352822A1 publication Critical patent/ES352822A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ES352822A 1967-04-19 1968-04-17 Procedimiento para la produccion de derivados de fenotiaci-na. Expired ES352822A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH558967A CH497458A (de) 1967-04-19 1967-04-19 Verfahren zur Herstellung neuer Phenothiazin-Derivate
CH1705667 1967-12-05

Publications (1)

Publication Number Publication Date
ES352822A1 true ES352822A1 (es) 1969-11-16

Family

ID=25698043

Family Applications (1)

Application Number Title Priority Date Filing Date
ES352822A Expired ES352822A1 (es) 1967-04-19 1968-04-17 Procedimiento para la produccion de derivados de fenotiaci-na.

Country Status (17)

Country Link
US (1) US3531480A (es)
AT (2) AT293372B (es)
AU (2) AU5480273A (es)
BE (1) BE713802A (es)
BG (1) BG17326A3 (es)
CH (1) CH497458A (es)
DE (1) DE1770218A1 (es)
ES (1) ES352822A1 (es)
FR (1) FR1583822A (es)
GB (2) GB1223314A (es)
IE (2) IE32170B1 (es)
IL (2) IL36239A (es)
NL (1) NL6804983A (es)
NO (1) NO124997B (es)
OA (1) OA03386A (es)
RO (1) RO54395A (es)
SE (2) SE361884B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857943A (en) * 1969-03-27 1974-12-31 May & Baker Ltd New phenothiazine derivatives in the treatment of spasticity of muscles
CH511886A (de) * 1969-07-08 1971-08-31 Sandoz Ag Verfahren zur Herstellung neuer Furanonderivate
US6310059B1 (en) * 1998-06-30 2001-10-30 Neuromed Technologies, Inc. Fused ring calcium channel blockers
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
WO2007133481A2 (en) * 2006-05-11 2007-11-22 Neuromed Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
JP2014507424A (ja) 2011-03-08 2014-03-27 ザリカス ファーマスーティカルズ リミテッド 固体分散物製剤およびその使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1212031A (fr) * 1957-10-21 1960-03-21 Rhone Poulenc Sa Dérivés de la phénothiazine substitués à l'azote par une chaîne basique comportant un hétérocycle et leur préparation

Also Published As

Publication number Publication date
IE32170L (en) 1968-10-19
IE32169B1 (en) 1973-05-02
AU5480273A (en) 1973-07-12
CH497458A (de) 1970-10-15
IE32169L (en) 1968-10-19
GB1223314A (en) 1971-02-24
IL29842A (en) 1971-05-26
BG17326A3 (es) 1973-07-25
GB1223315A (en) 1971-02-24
NL6804983A (es) 1968-10-21
DE1770218A1 (de) 1971-10-14
FR1583822A (es) 1969-12-05
US3531480A (en) 1970-09-29
IL36239A (en) 1971-06-23
OA03386A (fr) 1970-12-15
BE713802A (es) 1968-10-17
AT292726B (de) 1971-09-10
SE361884B (es) 1973-11-19
AT293372B (de) 1971-10-11
SE356520B (es) 1973-05-28
IL29842A0 (en) 1968-06-20
NO124997B (es) 1972-07-03
IE32170B1 (en) 1973-05-02
AU5480173A (en) 1973-07-12
RO54395A (es) 1973-02-17

Similar Documents

Publication Publication Date Title
IE40945L (en) Benzomorphane derivatives.
ES391497A1 (es) Procedimiento para la preparacion de nuevos derivados de ciclohepteno.
ES352822A1 (es) Procedimiento para la produccion de derivados de fenotiaci-na.
GB873925A (en) Improvements in or relating to aralkylbenzmorphan derivatives
GB1055055A (en) Improvements in or relating to 4-[1-lower alkyl piperidylidene-(4)]-9,10-dihydro-4h-benzo[4,5]-cyclohepta[1,2-b]thiophene derivatives
GB1277789A (en) Improvements in or relating to new polycyclic pyrrole derivatives
KR890001950A (ko) 4-아미노-치환된 1.2- 디하이드록시나프탈렌 유도체
GB1194505A (en) Piperidinol Derivatives and Process for Preparing Them
GB981192A (en) Improvements in or relating to 4 hydroxytryptamine esters
GB1314952A (en) 3,4,5-trialkoxy-benzoic acid derivatives and their uses
GB1351526A (en) Tropan-3-ol derivatives and processes for their preparation
JPS56120699A (en) 177aminoo166hydroxysteroid of novel androstane and estrane* its derivative and its drug composition
GB1336634A (en) 5,10-methano-dibenzo-a,d-cycloheptene derivatives and a process for their manufacture
US3627769A (en) 1-(4,5-DIHYDROTHIENO{8 2,3-b{9 {0 {8 1{9 {0 BENZOTHIEPIN-4-YL)-PIPERAZINES
GB949732A (en) New piperidine derivatives and process for their production
ES355553A1 (es) Un procedimiento para la preparacion de derivados de ergo- linicos.
GB1410872A (en) Tetrahydropyran and tetrahydrothiapyran derivatives
SE8804696D0 (sv) Dioxazocine derivatives their preparation and compositions containing them
ES294657A1 (es) Procedimiento para la producciën de nuevos compuestos heterociclicos
GB1159480A (en) 4H-Benzo[4,5]Cyclohepta[1,2-b]-Thiophene Derivatives
GB1227965A (es)
ES259622A1 (es) Proceso para la preparaciën decompuestos de la fërmula general:
GB1048555A (en) 6-methyl- and 1,6-dimethyl-ergoline i derivatives
GB1084449A (en) Improvements in or relating to 4h-benzo[4,5]cyclohepta[1,2-b]thiophene derivatives
ES372227A1 (es) Un procedimiento para la preparacion de una nueva clase de derivados ergolinicos.